As a leader who has committed much of his career to improving healthcare — an industry that holds millions of people’s lives ...

While employers are prioritizing mental and physical wellbeing programs, employees report that what they really want is financial wellbeing support, according to a new survey. The survey was ...

Over the past few years, the metabolic health space has been buzzing due to a mix of increasing awareness, novel drugs and personalized health tools. One of the most impactful developments in ...

Make no mistake: the hype surrounding generative AI in the healthcare sector is still going strong. Overall, the industry is excited about the technology’s potential to alleviate burnout ...

In a recent interview, Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health, discussed employers' ...

Burnout among clinicians and staff remains a significant issue in healthcare, with widespread implications for patient care, staff retention, and the financial health of healthcare organizations.

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million ...

Value-based care (VBC) models (which I’ve previously discussed) focus on reducing cost and improving health outcomes for defined “episodes” of care, with the expected cost of these episodes ...

Beam Therapeutics’ experimental gene-editing therapy for sickle cell disease now has its first cut of patient data showing signs of treating the rare blood disorder in a way that could ...